Honolulu Mayor Signs Law Prohibiting Sale of Herbal Cigarettes

Regulations by 2FIRSTS.ai
Apr.17.2024
Honolulu Mayor Signs Law Prohibiting Sale of Herbal Cigarettes
Honolulu Mayor Rick Blangiardi signs Bill 1, prohibiting sale of herbal cigarettes to those under 21, addressing tobacco law loopholes.

According to a report by khon2 on April 16th, the Mayor of Honolulu, Rick Blangiardi, has signed Bill 1, which prohibits the sale of herbal cigarettes to individuals under the age of 21.

 

Lawmakers stated that the signing of the bill is to address loopholes in Hawaii's existing tobacco laws. Because herbal cigarettes do not contain tobacco or nicotine, individuals under the age of 21 can purchase such products.

 

State Assemblyman Tyler Dos Santos-Tam stated that the state government has been working to make it more difficult for young people to purchase e-cigarettes. "Youth advocates in our community are pushing for statewide legislation to ban the sale of flavored tobacco products aimed at our youth, and the recent 46th bill (2023) reinstates local control over tobacco products. This measure further demonstrates that the city is prepared to pass and enforce laws that protect our youth."

 

The first bill requires companies selling herbal cigarettes to display signage and inform consumers under the age of 21 of the prohibition.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai
Charlie’s Holdings Signs Licensing Agreement with IKE Tech to Commercialize Age-Gated Vape Technology in the U.S.
Charlie’s Holdings Signs Licensing Agreement with IKE Tech to Commercialize Age-Gated Vape Technology in the U.S.
Charlie’s Holdings has signed a licensing agreement with IKE Tech to commercialize an age-gated vape activation system in the U.S. The technology combines biometric authentication, BLE hardware, and a mobile app for continuous device-level age verification. The company plans to test-market the system with SBX nicotine analogue products this spring and may later apply it to PACHA-branded ENDS.
News
Jan.06
Turkey Plans to Ban E-Cigarette Advertising Under Revised Commercial Advertising Rules
Turkey Plans to Ban E-Cigarette Advertising Under Revised Commercial Advertising Rules
Turkey is advancing amendments to its Regulation on Commercial Advertising and Unfair Commercial Practices, proposing stricter controls on e-cigarette and gambling advertising.
Dec.26 by 2FIRSTS.ai
Russia considers digital tagging for e-cigarette products to strengthen industry regulation
Russia considers digital tagging for e-cigarette products to strengthen industry regulation
Russia is considering digitizing e-cigarette products for better industry regulation, aiming to protect consumers and prevent counterfeit products.
Feb.05 by 2FIRSTS.ai
PMI launches IQOS Iluma i One in the UK, compatible with TEREA tobacco sticks
PMI launches IQOS Iluma i One in the UK, compatible with TEREA tobacco sticks
Philip Morris Limited (PML), the UK affiliate of Philip Morris International (PMI), has launched the latest addition to its heated tobacco IQOS lineup, the IQOS Iluma i One, in the UK. The device uses a bladeless induction-heating system and adds features such as a touchscreen and automatic start-up, while being designed for use with TEREA tobacco sticks, including the Pearls range.
Feb.10 by 2FIRSTS.ai
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International (PMI) said its U.S.-related investments have topped $20 billion since 2022, when it entered the U.S. market through its roughly $19 billion acquisition of Swedish Match. The company also said it plans to launch its heated tobacco product IQOS ILUMA in the United States pending authorization from the U.S. Food and Drug Administration (FDA).
Jan.16 by 2FIRSTS.ai